Orchard Therapeutics plc
ORTX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35 | -$12 | -$17 | -$8 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $1 | $0 | $0 | -$6 |
| Stock-Based Comp. | $2 | $3 | $4 | $4 |
| Change in WC | -$4 | -$6 | -$6 | $20 |
| Other Non-Cash | $11 | -$13 | -$11 | -$23 |
| Operating Cash Flow | -$24 | -$28 | -$30 | -$12 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$1 | -$0 |
| Net Acquisitions | -$12 | $27 | $9 | $0 |
| Inv. Purchases | -$32 | -$76 | -$39 | -$41 |
| Inv. Sales/Matur. | $44 | $49 | $30 | $32 |
| Other Inv. Act. | $12 | -$27 | -$9 | $8 |
| Investing Cash Flow | $12 | -$27 | -$9 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $34 | $34 | $0 |
| Stock Repurch. | -$0 | -$1 | -$0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | $31 | $32 | -$1 |
| Financing Cash Flow | -$2 | $31 | $32 | -$1 |
| Forex Effect | -$0 | $0 | $0 | $2 |
| Net Chg. in Cash | -$15 | -$23 | -$7 | -$12 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $42 | $66 | $73 | $85 |
| End Cash | $28 | $42 | $66 | $73 |
| Free Cash Flow | -$24 | -$28 | -$30 | -$13 |